Nigerian Medical Journal

ORIGINAL ARTICLE
Year
: 2016  |  Volume : 57  |  Issue : 6  |  Page : 324--328

Study of pentoxifylline effects on motility and viability of spermatozoa from infertile asthenozoospermic males


Aliye Ghasemzadeh1, Farid Karkon-Shayan2, Solmaz Yousefzadeh1, Mohammad Naghavi-Behzad3, Kobra Hamdi1 
1 Women's Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
2 Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
3 Medical Philosophy and History Research Center; Students' Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran

Correspondence Address:
Kobra Hamdi
Women«SQ»s Reproductive Health Research Center, Tabriz University of Medical Science, Daneshgah Street, Tabriz, Eastern Azerbaijan
Iran

Background: The quality of semen is one of the major parameters in male infertility. Pentoxifylline, a methylxanthine derivative, is an agent primarily used in the treatment of intermittent claudication and other vascular disorders. Studies have shown that pentoxifylline enhances the quality and quantity of sperms. In this study, we have investigated the in vitro effects of pentoxifylline on viability and motility of spermatozoa in samples of infertile oligoasthenozoospermic males. Materials and Methods: In this observer-blinded clinical trial, semen samples of 25 infertile oligoasthenozoospermic males were collected in Alzahra Educational Medical Center of Tabriz University of Medical Sciences from August 2010 to August 2012. After the isolation of spermatozoa by the swim-up method, they were randomized into four groups in ISM1 environment: The controls treated normally: Group 1 treated by pentoxifylline at a dose of 50 ΅g/ml, Group 2 treated by pentoxifylline at a dose of 100 ΅g/ml, and Group 3 treated by pentoxifylline at a dose of 200 ΅g/ml. Sperm viability and motility were compared among the groups on 45 min, 24 h, 36 h, and 48 h intervals. Results: Mean percentages of live sperms were 98.40%, 51.40%, 20.60%, and 6.00% in control group and 98.40%, 69.20%, 38.60%, and 14.60% in Group 3 on the mentioned intervals, respectively. This mean percentage decrease of live sperms was significantly lower in Group 3 comparing with that of other groups (P = 0.01). Mean percentages of motile sperms were 54%, 8.40%, 2.80%, and 0% in control group; and 54%, 16%, 4.80%, and 1.40% in Group 3 on the mentioned intervals, respectively. There was not a significant difference between the four groups in this regard (P = 0.19). Conclusion: Pentoxifylline can enhance the viability of sperm of infertile oligoasthenozoospermic males with no significant effect on its motility.


How to cite this article:
Ghasemzadeh A, Karkon-Shayan F, Yousefzadeh S, Naghavi-Behzad M, Hamdi K. Study of pentoxifylline effects on motility and viability of spermatozoa from infertile asthenozoospermic males.Niger Med J 2016;57:324-328


How to cite this URL:
Ghasemzadeh A, Karkon-Shayan F, Yousefzadeh S, Naghavi-Behzad M, Hamdi K. Study of pentoxifylline effects on motility and viability of spermatozoa from infertile asthenozoospermic males. Niger Med J [serial online] 2016 [cited 2017 Apr 30 ];57:324-328
Available from: http://www.nigeriamedj.com/article.asp?issn=0300-1652;year=2016;volume=57;issue=6;spage=324;epage=328;aulast=Ghasemzadeh;type=0